Teva $35M Delayed Generic Inhalers Deal Gets Initial OK
By Kellie Mejdrich · April 2, 2026, 4:10 PM EDT
A Massachusetts federal judge Thursday granted initial approval to a $35 million deal that Teva Pharmaceuticals agreed to pay to resolve claims from a coalition of union healthcare funds that say...
To view the full article, register now.